Current Liabilities
Other accrued liabilities
Boston Scientific Other accrued liabilities decreased by 7.8% to $795.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 10.4%, from $887.00M to $795.00M. Over 5 years (FY 2020 to FY 2025), Other accrued liabilities shows a downward trend with a -3.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
Significant changes should be analyzed to determine if they represent one-time adjustments or shifts in operational expense timing.
Detailed definition
This represents miscellaneous short-term obligations that do not fall into standard categories like accounts payable or...
Peer comparison
Standard residual category; peers report this as other current liabilities.
Metric ID:
current_liabilities_other_liabilities_currentHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $680.00M | $669.00M | $783.00M | $1.03B | $784.00M | $752.00M | $761.00M | $787.00M | $940.00M | $882.00M | $814.00M | $827.00M | $770.00M | $891.00M | $887.00M | $923.00M | $952.00M | $862.00M | $795.00M |
| QoQ Change | — | -1.6% | +17.0% | +32.1% | -24.2% | -4.1% | +1.2% | +3.4% | +19.4% | -6.2% | -7.7% | +1.6% | -6.9% | +15.7% | -0.4% | +4.1% | +3.1% | -9.5% | -7.8% |
| YoY Change | — | — | — | — | +15.3% | +12.4% | -2.8% | -23.9% | +19.9% | +17.3% | +7.0% | +5.1% | -18.1% | +1.0% | +9.0% | +11.6% | +23.6% | -3.3% | -10.4% |
Range$669.00M – $1.03B
CAGR+3.5%
Avg YoY Growth+4.3%
Median YoY Growth+7.0%
Current Streak2 quarters decline
Other accrued liabilities at Other Companies
Frequently Asked Questions
- What is Boston Scientific's other accrued liabilities?
- Boston Scientific (BSX) reported other accrued liabilities of $795.00M in Q4 2025.
- How has Boston Scientific's other accrued liabilities changed year-over-year?
- Boston Scientific's other accrued liabilities decreased by 10.4% year-over-year, from $887.00M to $795.00M.
- What is the long-term trend for Boston Scientific's other accrued liabilities?
- Over 5 years (2020 to 2025), Boston Scientific's other accrued liabilities has grown at a -3.7% compound annual growth rate (CAGR), from $958.00M to $795.00M.
- What does other accrued liabilities mean?
- Miscellaneous short-term debts that do not fit into standard categories like accounts payable.